Allometric scaling can be utilized for the extrapolation of pharmacokinetic parameters from adults to kids. The target of this examine was to predict clearance of therapeutic proteins (monoclonal and polyclonal antibodies and non-antibody proteins) allometrically in preterm neonates to adolescents.

There have been 13 monoclonal antibodies, seven polyclonal antibodies, and 9 therapeutic proteins (non-antibodies) within the examine. The clearance of therapeutic proteins was predicted utilizing the age dependent exponents (ADE) mannequin after which in contrast with the noticed clearance values.

There have been in whole 29 therapeutic proteins on this examine with 75 observations. The variety of observations with ≤30%, ≤50%, and >50% prediction error was 60 (80%), 72 (96%), and be 3 (4%), respectively. Total, the anticipated clearance values of therapeutic proteins in kids was good.

The allometric methodology proposed on this manuscript can be utilized to pick out first-in-pediatric dose of therapeutic proteins in pediatric medical trials.

Key phrases: allometry; kids; clearance; monoclonal antibodies; polyclonal antibodies; therapeutic proteins.

Rabies is a deadly zoonotic illness endemic in creating international locations of Asia and Africa. Just lately, the direct fast immunohistochemical take a look at (DRIT) was really useful by the World Well being Group (WHO) and the World Group for Animal Well being (OIE) as a diagnostic take a look at for rabies.

Subsequently, a biotinylated polyclonal antibody (pAb) towards the rabies lyssavirus (RABV) nucleoprotein was developed utilizing a plasmid cDNA vaccine derived from a problem virus commonplace 11 pressure. A preliminary analysis on the efficacy of this reagent in recognizing the Philippine RABV pressure was examined utilizing banked canine hippocampal tissue samples with DRIT and the outcomes had been in comparison with dFAT.

The consequences of acetone and formalin fixation on DRIT had been additionally assessed by way of immunoreactivity scores of the specimens. Of the 142 samples examined, 104 examined optimistic and 38 destructive utilizing each dFAT and DRIT, displaying 100% settlement between the 2 diagnostic procedures. Furthermore, no false optimistic or false destructive outcomes had been noticed utilizing acetone and formalin fixation.

Thus, regionally ready biotinylated pAb from plasmid cDNA can be utilized for DRIT, particularly in resource-limited laboratories within the Philippines. Nonetheless, these outcomes ought to be confirmed with a extra thorough analysis of this system, and the vary of detection must be additional evaluated in a bigger panel of animal samples and on different lyssav viruses.

Key phrases: DRIT; Analysis; Fixation; Immunohistochemistry; Rabies; dFAT.

PIBF1 Antibody
1-CSB-PA828391	Cusabio	EUR 380.40 EUR 292.80	100ul 50ul
Description: A polyclonal antibody against PIBF1. Recognizes PIBF1 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:1000-1:2000, WB:1:200-1:1000, IHC:1:25-1:100

PIBF1 Antibody
1-CSB-PA889657	Cusabio	EUR 380.40 EUR 292.80	100ul 50ul
Description: A polyclonal antibody against PIBF1. Recognizes PIBF1 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:5000, IHC:1:50-1:200

PIBF1 Antibody
1-CSB-PA017961GA01HU	Cusabio	EUR 716.40 EUR 399.60	150ul 50ul
Description: A polyclonal antibody against PIBF1. Recognizes PIBF1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB

Polyclonal PIBF1 Antibody
APR06805G	Leading Biology	0.1 mg	EUR 790.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human PIBF1 . This antibody is tested and proven to work in the following applications:

PIBF1 Conjugated Antibody
C38564	SAB	100ul	EUR 476.4

PIBF1 Conjugated Antibody
C31261	SAB	100ul	EUR 476.4

Polyclonal PIBF1 / PIBF Antibody (C-Terminus)
APR03127G	Leading Biology	0.05mg	EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human PIBF1 / PIBF (C-Terminus). This antibody is tested and proven to work in the following applications:

Progesterone-Induced-Blocking Factor 1 (PIBF1) Antibody
abx236433-100ug	Abbexa	100 ug	EUR 577.2

Progesterone-Induced-Blocking Factor 1 (PIBF1) Antibody
20-abx126358	Abbexa	EUR 493.20 EUR 710.40 EUR 218.40 EUR 376.80	100 ul 200 ul 20 ul 50 ul

Progesterone-Induced-Blocking Factor 1 (PIBF1) Antibody
20-abx002214	Abbexa	EUR 493.20 EUR 710.40 EUR 218.40 EUR 376.80	100 ul 200 ul 20 ul 50 ul

Progesterone Immunomodulatory Binding Factor 1 (PIBF1) Antibody
20-abx174168	Abbexa	EUR 1111.20 EUR 560.40	1 mg 200 ug

Progesterone Immunomodulatory Binding Factor 1 (PIBF1) Antibody
20-abx211035	Abbexa	EUR 493.20 EUR 360.00	100 ul 50 ul

Progesterone Immunomodulatory Binding Factor 1 (PIBF1) Antibody
20-abx114691	Abbexa	EUR 878.40 EUR 477.60	150 ul 50 ul

Progesterone Immunomodulatory Binding Factor 1 (PIBF1) Antibody
20-abx129293	Abbexa	EUR 543.60 EUR 159.60 EUR 1579.20 EUR 744.00 EUR 410.40	100 ug 10 ug 1 mg 200 ug 50 ug

Progesterone Immunomodulatory Binding Factor 1 (PIBF1) Antibody
20-abx339511	Abbexa	EUR 493.20 EUR 360.00	100 ul 50 ul

PIBF1 siRNA
20-abx928540	Abbexa	EUR 661.20 EUR 878.40	15 nmol 30 nmol

PIBF1 Peptide
7237P	ProSci	0.05 mg	EUR 197.7
Description: (CT) PIBF1 Peptide

PIBF1 Rabbit pAb
A12033-100ul	Abclonal	100 ul	EUR 369.6

PIBF1 Rabbit pAb
A12033-200ul	Abclonal	200 ul	EUR 550.8

PIBF1 Rabbit pAb
A12033-20ul	Abclonal	20 ul	EUR 219.6

PIBF1 Rabbit pAb
A12033-50ul	Abclonal	50 ul	EUR 267.6

PIBF1 Rabbit pAb
A3072-100ul	Abclonal	100 ul	EUR 369.6

PIBF1 Rabbit pAb
A3072-200ul	Abclonal	200 ul	EUR 550.8

PIBF1 Rabbit pAb
A3072-20ul	Abclonal	20 ul	EUR 219.6

PIBF1 Rabbit pAb
A3072-50ul	Abclonal	50 ul	EUR 267.6

PIBF1 Blocking Peptide
33R-7990	Fitzgerald	100 ug	EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of PIBF1 antibody, catalog no. 70R-9148

PIBF1 Blocking Peptide
DF7171-BP	Affbiotech	1mg	EUR 234

Progesterone Immunomodulatory Binding Factor 1 (PIBF1) Polyclonal Antibody (Human)
4-PAN433Hu01	Cloud-Clone	EUR 314.40 EUR 3296.40 EUR 814.80 EUR 397.20 EUR 264.00	100ul 10ml 1ml 200ul 20ul
Description: A Rabbit polyclonal antibody against Human Progesterone Immunomodulatory Binding Factor 1 (PIBF1)

Human PIBF1 ELISA Kit
ELA-E1563h	Lifescience Market	96 Tests	EUR 988.8

Progesterone Immunomodulatory Binding Factor 1 (PIBF1) Polyclonal Antibody (Human), PE
4-PAN433Hu01-PE	Cloud-Clone	EUR 376.80 EUR 3478.80 EUR 976.80 EUR 476.40 EUR 243.60	100ul 10ml 1ml 200ul 20ul
Description: A Rabbit polyclonal antibody against Human Progesterone Immunomodulatory Binding Factor 1 (PIBF1). This antibody is labeled with PE.

Progesterone Immunomodulatory Binding Factor 1 (PIBF1) Polyclonal Antibody (Human), APC
4-PAN433Hu01-APC	Cloud-Clone	EUR 441.60 EUR 4318.80 EUR 1191.60 EUR 566.40 EUR 274.80	100ul 10ml 1ml 200ul 20ul
Description: A Rabbit polyclonal antibody against Human Progesterone Immunomodulatory Binding Factor 1 (PIBF1). This antibody is labeled with APC.

Progesterone Immunomodulatory Binding Factor 1 (PIBF1) Polyclonal Antibody (Human), Cy3
4-PAN433Hu01-Cy3	Cloud-Clone	EUR 538.80 EUR 5708.40 EUR 1539.60 EUR 705.60 EUR 316.80	100ul 10ml 1ml 200ul 20ul
Description: A Rabbit polyclonal antibody against Human Progesterone Immunomodulatory Binding Factor 1 (PIBF1). This antibody is labeled with Cy3.

Progesterone Immunomodulatory Binding Factor 1 (PIBF1) Polyclonal Antibody (Human), FITC
4-PAN433Hu01-FITC	Cloud-Clone	EUR 376.80 EUR 3478.80 EUR 976.80 EUR 476.40 EUR 243.60	100ul 10ml 1ml 200ul 20ul
Description: A Rabbit polyclonal antibody against Human Progesterone Immunomodulatory Binding Factor 1 (PIBF1). This antibody is labeled with FITC.

Progesterone Immunomodulatory Binding Factor 1 (PIBF1) Polyclonal Antibody (Human), HRP
4-PAN433Hu01-HRP	Cloud-Clone	EUR 402.00 EUR 3762.00 EUR 1052.40 EUR 511.20 EUR 258.00	100ul 10ml 1ml 200ul 20ul
Description: A Rabbit polyclonal antibody against Human Progesterone Immunomodulatory Binding Factor 1 (PIBF1). This antibody is labeled with HRP.

Human PIBF1 shRNA Plasmid
20-abx957102	Abbexa	EUR 961.20 EUR 1345.20	150 µg 300 µg

Progesterone Immunomodulatory Binding Factor 1 (PIBF1) Polyclonal Antibody (Human), Biotinylated
4-PAN433Hu01-Biotin	Cloud-Clone	EUR 393.60 EUR 3236.40 EUR 943.20 EUR 484.80 EUR 271.20	100ul 10ml 1ml 200ul 20ul
Description: A Rabbit polyclonal antibody against Human Progesterone Immunomodulatory Binding Factor 1 (PIBF1). This antibody is labeled with Biotin.

PIBF1 Recombinant Protein (Mouse)
RP161978	ABM	100 ug	Ask for price

PIBF1 Recombinant Protein (Mouse)
RP161981	ABM	100 ug	Ask for price

PIBF1 Recombinant Protein (Human)
RP083220	ABM	100 ug	Ask for price

Progesterone Immunomodulatory Binding Factor 1 (PIBF1) Polyclonal Antibody (Human), APC-Cy7
4-PAN433Hu01-APC-Cy7	Cloud-Clone	EUR 739.20 EUR 8493.60 EUR 2240.40 EUR 988.80 EUR 405.60	100ul 10ml 1ml 200ul 20ul
Description: A Rabbit polyclonal antibody against Human Progesterone Immunomodulatory Binding Factor 1 (PIBF1). This antibody is labeled with APC-Cy7.

PIBF1 ORF Vector (Human) (pORF)
ORF027741	ABM	1.0 ug DNA	EUR 486

Pibf1 ORF Vector (Mouse) (pORF)
ORF053994	ABM	1.0 ug DNA	EUR 607.2

Pibf1 ORF Vector (Mouse) (pORF)
ORF053995	ABM	1.0 ug DNA	EUR 607.2

PIBF1 ELISA Kit (Human) (OKEH01125)
OKEH01125	Aviva Systems Biology	96 Wells	EUR 794.4
Description: Description of target: ;Species reactivity: Human;Application: ELISA;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.34 ng/mL

PIBF1 ELISA Kit (Human) (OKCD09391)
OKCD09391	Aviva Systems Biology	96 Wells	EUR 1090.8
Description: Description of target: PIBF1 is the mediator of progesterone that by acting on the phospholipase A2 enzyme interferes with arachidonic acid metabolism, induces a Th2 biased immune response, and by controlling NK activity exerts an anti-abortive effect.;Species reactivity: Human;Application: ELISA;Assay info: ;Sensitivity: < 0.116ng/mL

PIBF1 ELISA Kit (Mouse) (OKEI00591)
OKEI00591	Aviva Systems Biology	96 Wells	EUR 920.4
Description: Description of target: ;Species reactivity: Mouse;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.469 ng/mL

Pibf1 3'UTR GFP Stable Cell Line
TU166340	ABM	1.0 ml	Ask for price

PIBF1 3'UTR GFP Stable Cell Line
TU067921	ABM	1.0 ml	EUR 1672.8

Pibf1 3'UTR GFP Stable Cell Line
TU266218	ABM	1.0 ml	Ask for price

Pibf1 sgRNA CRISPR Lentivector set (Mouse)
K4607801	ABM	3 x 1.0 ug	EUR 406.8

PIBF1 sgRNA CRISPR Lentivector set (Human)
K1646101	ABM	3 x 1.0 ug	EUR 406.8

PIBF1 Protein Vector (Human) (pPM-C-HA)
PV110964	ABM	500 ng	EUR 973.2

PIBF1 Protein Vector (Mouse) (pPM-C-HA)
PV215976	ABM	500 ng	EUR 1278

PIBF1 Protein Vector (Mouse) (pPM-C-HA)
PV215980	ABM	500 ng	EUR 723.6

PIBF1 Protein Vector (Human) (pPB-C-His)
PV110962	ABM	500 ng	EUR 394.8

PIBF1 Protein Vector (Human) (pPB-N-His)
PV110963	ABM	500 ng	EUR 973.2

PIBF1 Protein Vector (Human) (pPM-C-His)
PV110965	ABM	500 ng	EUR 973.2

PIBF1 Protein Vector (Mouse) (pPB-C-His)
PV215974	ABM	500 ng	EUR 1278

PIBF1 Protein Vector (Mouse) (pPB-N-His)
PV215975	ABM	500 ng	EUR 1278

PIBF1 Protein Vector (Mouse) (pPM-C-His)
PV215977	ABM	500 ng	EUR 1278

PIBF1 Protein Vector (Mouse) (pPB-C-His)
PV215978	ABM	500 ng	EUR 723.6

PIBF1 Protein Vector (Mouse) (pPB-N-His)
PV215979	ABM	500 ng	EUR 723.6

PIBF1 Protein Vector (Mouse) (pPM-C-His)
PV215981	ABM	500 ng	EUR 723.6

Pibf1 3'UTR Luciferase Stable Cell Line
TU116340	ABM	1.0 ml	Ask for price

PIBF1 3'UTR Luciferase Stable Cell Line
TU017921	ABM	1.0 ml	EUR 1672.8

Pibf1 3'UTR Luciferase Stable Cell Line
TU216218	ABM	1.0 ml	Ask for price

Pibf1 sgRNA CRISPR Lentivector (Mouse) (Target 1)
K4607802	ABM	1.0 ug DNA	EUR 184.8

Pibf1 sgRNA CRISPR Lentivector (Mouse) (Target 2)
K4607803	ABM	1.0 ug DNA	EUR 184.8

Pibf1 sgRNA CRISPR Lentivector (Mouse) (Target 3)
K4607804	ABM	1.0 ug DNA	EUR 184.8

PIBF1 sgRNA CRISPR Lentivector (Human) (Target 1)
K1646102	ABM	1.0 ug DNA	EUR 184.8

PIBF1 sgRNA CRISPR Lentivector (Human) (Target 2)
K1646103	ABM	1.0 ug DNA	EUR 184.8

PIBF1 sgRNA CRISPR Lentivector (Human) (Target 3)
K1646104	ABM	1.0 ug DNA	EUR 184.8

Human Progesterone-induced-blocking factor 1 (PIBF1)
1-CSB-CF845171HU	Cusabio	EUR 1158.00 EUR 798.00 EUR 858.00	1MG 200ug 500ug
Description: Recombinant Human Progesterone-induced-blocking factor 1(PIBF1) expressed in in vitro E.coli expression system

Recombinant Progesterone Immunomodulatory Binding Factor 1 (PIBF1)
4-RPN433Hu01	Cloud-Clone	EUR 580.19 EUR 278.40 EUR 1845.70 EUR 695.23 EUR 1270.46 EUR 463.20 EUR 4434.24	100 ug 10ug 1 mg 200 ug 500 ug 50ug 5 mg
Description: Recombinant Human Progesterone Immunomodulatory Binding Factor 1 expressed in: E.coli

ApoB antibody
20C-CR2009GP	Fitzgerald	1 mg	EUR 198
Description: Goat polyclonal ApoB antibody (IgG Fraction)

ApoB antibody
20C-CR2009RP	Fitzgerald	1 mg	EUR 198
Description: Rabbit polyclonal ApoB antibody

ApoB antibody
20C-CR2009SP	Fitzgerald	1 ml	EUR 440.4
Description: Sheep polyclonal ApoB antibody (Purified IgG)

ApoB antibody
20R-1695	Fitzgerald	100 ug	EUR 807.6
Description: Goat polyclonal ApoB antibody

ApoB antibody
20-AG40S	Fitzgerald	5 ml	EUR 178.8
Description: Goat polyclonal ApoB antibody

ApoB antibody
20-S1151G000-V0	Fitzgerald	10 ml	EUR 159.6
Description: Goat polyclonal Human ApoB antibody

ApoB Antibody
BF0278	Affbiotech	200ul	EUR 540

ApoB antibody
70C-CR2009GAP	Fitzgerald	1 mg	EUR 442.8
Description: Affinity purified Goat polyclonal ApoB antibody

APOB antibody
70R-15771	Fitzgerald	50 ul	EUR 405.6
Description: Rabbit polyclonal APOB antibody

ApoB antibody
70R-7483	Fitzgerald	50 ug	EUR 560.4
Description: Rabbit polyclonal ApoB antibody raised against the middle region of APOB

APOB Antibody
36751-100ul	SAB	100ul	EUR 302.4

APOB Antibody
DF12533	Affbiotech	200ul	EUR 420

APOB Antibody
1-CSB-PA318254	Cusabio	EUR 380.40 EUR 292.80	100ul 50ul
Description: A polyclonal antibody against APOB. Recognizes APOB from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:1000-1:5000, IHC:1:15-1:50

APOB Antibody
1-CSB-PA780260	Cusabio	EUR 380.40 EUR 292.80	100ul 50ul
Description: A polyclonal antibody against APOB. Recognizes APOB from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:1000-1:5000, IHC:1:15-1:50

APOB Antibody
1-CSB-PA001918GA01HU	Cusabio	EUR 716.40 EUR 399.60	150ul 50ul
Description: A polyclonal antibody against APOB. Recognizes APOB from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB

APOB Antibody
1-CSB-PA001918LA01HU	Cusabio	EUR 380.40 EUR 402.00	100ug 50ug
Description: A polyclonal antibody against APOB. Recognizes APOB from Human. This antibody is Unconjugated. Tested in the following application: ELISA

APOB Antibody
R36144-100UG	NSJ Bioreagents	100 ug	EUR 339.15
Description: Additional name(s) for this target protein: Apolipoprotein B

APOB Antibody
R32510	NSJ Bioreagents	100 ug	EUR 356.15
Description: Apolipoprotein B (ApoB) is a protein that in humans is encoded by the APOB gene. This gene product is the main apolipoprotein of chylomicrons and low density lipoproteins. It occurs in plasma as two main isoforms, apoB-48 and apoB-100: the former is synthesized exclusively in the gut and the latter in the liver. The intestinal and the hepatic forms of apoB are encoded by a single gene from a single, very long mRNA. The two isoforms share a common N-terminal sequence. The shorter apoB-48 protein is produced after RNA editing of the apoB-100 transcript at residue 2180 (CAA->UAA), resulting in the creation of a stop codon, and early translation termination. Mutations in this gene or its regulatory region cause hypobetalipoproteinemia, normotriglyceridemic hypobetalipoproteinemia, and hypercholesterolemia due to ligand-defective apoB, diseases affecting plasma cholesterol and apoB levels.

Anti-Apolipoprotein B/APOB Antibody
PB10042	BosterBio	100ug/vial	EUR 400.8

APOB Antibody, HRP conjugated
1-CSB-PA001918LB01HU	Cusabio	EUR 380.40 EUR 402.00	100ug 50ug
Description: A polyclonal antibody against APOB. Recognizes APOB from Human. This antibody is HRP conjugated. Tested in the following application: ELISA

Apolipoprotein B (APOB) Antibody
abx230491-100ug	Abbexa	100 ug	EUR 610.8

Apolipoprotein B (APOB) Antibody
20-abx175426	Abbexa	EUR 526.80 EUR 159.60 EUR 1479.60 EUR 710.40 EUR 393.60	100 ug 10 ug 1 mg 200 ug 50 ug

Apolipoprotein B (APOB) Antibody
20-abx175427	Abbexa	EUR 526.80 EUR 159.60 EUR 1479.60 EUR 710.40 EUR 393.60	100 ug 10 ug 1 mg 200 ug 50 ug

Apolipoprotein B (APOB) Antibody
20-abx171274	Abbexa	EUR 1178.40 EUR 594.00	1 mg 200 ug

Apolipoprotein B (APOB) Antibody
20-abx214431	Abbexa	EUR 493.20 EUR 360.00	100 ul 50 ul

Apolipoprotein B (APOB) Antibody
20-abx214432	Abbexa	EUR 493.20 EUR 360.00	100 ul 50 ul

Apolipoprotein B (APOB) Antibody
20-abx111022	Abbexa	EUR 878.40 EUR 477.60	150 ul 50 ul

Apolipoprotein B (APOB) Antibody
20-abx101439	Abbexa	EUR 427.20 EUR 159.60 EUR 1195.20 EUR 594.00 EUR 360.00	100 ug 10 ug 1 mg 200 ug 50 ug

Apolipoprotein B (APOB) Antibody
20-abx101440	Abbexa	EUR 526.80 EUR 159.60 EUR 1479.60 EUR 710.40 EUR 393.60	100 ug 10 ug 1 mg 200 ug 50 ug

Apolipoprotein B (APOB) Antibody
20-abx101441	Abbexa	EUR 543.60 EUR 159.60 EUR 1562.40 EUR 744.00 EUR 410.40	100 ug 10 ug 1 mg 200 ug 50 ug

Apolipoprotein B (APOB) Antibody
20-abx101443	Abbexa	EUR 577.20 EUR 159.60 EUR 1696.80 EUR 794.40 EUR 427.20	100 ug 10 ug 1 mg 200 ug 50 ug

Apolipoprotein B (APOB) Antibody
abx432338-200ul	Abbexa	200 ul	EUR 460.8

Apolipoprotein B (APOB) Antibody
20-abx000052	Abbexa	EUR 594.00 EUR 844.80 EUR 427.20	100 ul 200 ul 50 ul

Apolipoprotein B (APOB) Antibody
20-abx001189	Abbexa	EUR 493.20 EUR 710.40 EUR 218.40 EUR 376.80	100 ul 200 ul 20 ul 50 ul

Apolipoprotein B (ApoB) Antibody
abx012218-100ul	Abbexa	100 ul	EUR 493.2

Apolipoprotein B (APOB) Antibody
20-abx303086	Abbexa	EUR 493.20 EUR 2214.00 EUR 718.80 EUR 218.40 EUR 360.00	100 ug 1 mg 200 ug 20 ug 50 ug

APOB Antibody / Apolipoprotein B
V8941-100UG	NSJ Bioreagents	100ug	EUR 349.3
Description: Post-transcriptional editing of apolipoprotein B (apoB) mRNA is regulated by APOBEC1 (also designated human (or rat) small intestinal apolipoprotein B mRNA editing protein, HEPR or REPR) in hepatic cells to achieve a steady state proportion of edited and unedited RNA molecules. Two forms of apoB are known to circulate in the plasma of mammals. ApoB-100 is a protein primarily synthesized in the liver as a structural component of very low density lipoprotein particles. A truncated form of apoB-100, apoB-48, is synthesized in the small intestine and contains the amino-terminal 2,152 amino acids of the larger protein. This organ-specific partitioning of apoB production is the result of RNA editing of a common apoB gene.

APOB Antibody / Apolipoprotein B
V8941-20UG	NSJ Bioreagents	20ug	EUR 153.3
Description: Post-transcriptional editing of apolipoprotein B (apoB) mRNA is regulated by APOBEC1 (also designated human (or rat) small intestinal apolipoprotein B mRNA editing protein, HEPR or REPR) in hepatic cells to achieve a steady state proportion of edited and unedited RNA molecules. Two forms of apoB are known to circulate in the plasma of mammals. ApoB-100 is a protein primarily synthesized in the liver as a structural component of very low density lipoprotein particles. A truncated form of apoB-100, apoB-48, is synthesized in the small intestine and contains the amino-terminal 2,152 amino acids of the larger protein. This organ-specific partitioning of apoB production is the result of RNA editing of a common apoB gene.

APOB Antibody / Apolipoprotein B
V8941SAF-100UG	NSJ Bioreagents	100ug	EUR 349.3
Description: Post-transcriptional editing of apolipoprotein B (apoB) mRNA is regulated by APOBEC1 (also designated human (or rat) small intestinal apolipoprotein B mRNA editing protein, HEPR or REPR) in hepatic cells to achieve a steady state proportion of edited and unedited RNA molecules. Two forms of apoB are known to circulate in the plasma of mammals. ApoB-100 is a protein primarily synthesized in the liver as a structural component of very low density lipoprotein particles. A truncated form of apoB-100, apoB-48, is synthesized in the small intestine and contains the amino-terminal 2,152 amino acids of the larger protein. This organ-specific partitioning of apoB production is the result of RNA editing of a common apoB gene.

APOB Antibody / Apolipoprotein B
V9160-100UG	NSJ Bioreagents	100ug	EUR 349.3
Description: Post-transcriptional editing of apolipoprotein B (apoB) mRNA is regulated by APOBEC1 (also designated human (or rat) small intestinal apolipoprotein B mRNA editing protein, HEPR or REPR) in hepatic cells to achieve a steady state proportion of edited and unedited RNA molecules. Two forms of apoB are known to circulate in the plasma of mammals. ApoB-100 is a protein primarily synthesized in the liver as a structural component of very low density lipoprotein particles. A truncated form of apoB-100, apoB-48, is synthesized in the small intestine and contains the amino-terminal 2,152 amino acids of the larger protein. This organ-specific partitioning of apoB production is the result of RNA editing of a common apoB gene.

APOB Antibody / Apolipoprotein B
V9160-20UG	NSJ Bioreagents	20ug	EUR 153.3
Description: Post-transcriptional editing of apolipoprotein B (apoB) mRNA is regulated by APOBEC1 (also designated human (or rat) small intestinal apolipoprotein B mRNA editing protein, HEPR or REPR) in hepatic cells to achieve a steady state proportion of edited and unedited RNA molecules. Two forms of apoB are known to circulate in the plasma of mammals. ApoB-100 is a protein primarily synthesized in the liver as a structural component of very low density lipoprotein particles. A truncated form of apoB-100, apoB-48, is synthesized in the small intestine and contains the amino-terminal 2,152 amino acids of the larger protein. This organ-specific partitioning of apoB production is the result of RNA editing of a common apoB gene.

APOB Antibody / Apolipoprotein B
V9160SAF-100UG	NSJ Bioreagents	100ug	EUR 349.3
Description: Post-transcriptional editing of apolipoprotein B (apoB) mRNA is regulated by APOBEC1 (also designated human (or rat) small intestinal apolipoprotein B mRNA editing protein, HEPR or REPR) in hepatic cells to achieve a steady state proportion of edited and unedited RNA molecules. Two forms of apoB are known to circulate in the plasma of mammals. ApoB-100 is a protein primarily synthesized in the liver as a structural component of very low density lipoprotein particles. A truncated form of apoB-100, apoB-48, is synthesized in the small intestine and contains the amino-terminal 2,152 amino acids of the larger protein. This organ-specific partitioning of apoB production is the result of RNA editing of a common apoB gene.

APOB Antibody / Apolipoprotein B
V8461-100UG	NSJ Bioreagents	100 ug	EUR 349.3
Description: Post-transcriptional editing of apolipoprotein B (apoB) mRNA is regulated by APOBEC1 (also designated human (or rat) small intestinal apolipoprotein B mRNA editing protein, HEPR or REPR) in hepatic cells to achieve a steady state proportion of edited and unedited RNA molecules. Two forms of apoB are known to circulate in the plasma of mammals. ApoB-100 is a protein primarily synthesized in the liver as a structural component of very low density lipoprotein particles. A truncated form of apoB-100, apoB-48, is synthesized in the small intestine and contains the amino-terminal 2,152 amino acids of the larger protein. This organ-specific partitioning of apoB production is the resultof RNA editing of a common apoB gene.

APOB Antibody / Apolipoprotein B
V8461-20UG	NSJ Bioreagents	20 ug	EUR 153.3
Description: Post-transcriptional editing of apolipoprotein B (apoB) mRNA is regulated by APOBEC1 (also designated human (or rat) small intestinal apolipoprotein B mRNA editing protein, HEPR or REPR) in hepatic cells to achieve a steady state proportion of edited and unedited RNA molecules. Two forms of apoB are known to circulate in the plasma of mammals. ApoB-100 is a protein primarily synthesized in the liver as a structural component of very low density lipoprotein particles. A truncated form of apoB-100, apoB-48, is synthesized in the small intestine and contains the amino-terminal 2,152 amino acids of the larger protein. This organ-specific partitioning of apoB production is the resultof RNA editing of a common apoB gene.

APOB Antibody / Apolipoprotein B
V8461SAF-100UG	NSJ Bioreagents	100 ug	EUR 349.3
Description: Post-transcriptional editing of apolipoprotein B (apoB) mRNA is regulated by APOBEC1 (also designated human (or rat) small intestinal apolipoprotein B mRNA editing protein, HEPR or REPR) in hepatic cells to achieve a steady state proportion of edited and unedited RNA molecules. Two forms of apoB are known to circulate in the plasma of mammals. ApoB-100 is a protein primarily synthesized in the liver as a structural component of very low density lipoprotein particles. A truncated form of apoB-100, apoB-48, is synthesized in the small intestine and contains the amino-terminal 2,152 amino acids of the larger protein. This organ-specific partitioning of apoB production is the resultof RNA editing of a common apoB gene.

APOB Antibody / Apolipoprotein B
V8609-100UG	NSJ Bioreagents	100 ug	EUR 349.3
Description: Post-transcriptional editing of apolipoprotein B (apoB) mRNA is regulated by APOBEC1 (also designated human (or rat) small intestinal apolipoprotein B mRNA editing protein, HEPR or REPR) in hepatic cells to achieve a steady state proportion of edited and unedited RNA molecules. Two forms of apoB are known to circulate in the plasma of mammals. ApoB-100 is a protein primarily synthesized in the liver as a structural component of very low density lipoprotein particles. A truncated form of apoB-100, apoB-48, is synthesized in the small intestine and contains the amino-terminal 2,152 amino acids of the larger protein. This organ-specific partitioning of apoB production is the resultof RNA editing of a common apoB gene.

APOB Antibody / Apolipoprotein B
V8609-20UG	NSJ Bioreagents	20 ug	EUR 153.3
Description: Post-transcriptional editing of apolipoprotein B (apoB) mRNA is regulated by APOBEC1 (also designated human (or rat) small intestinal apolipoprotein B mRNA editing protein, HEPR or REPR) in hepatic cells to achieve a steady state proportion of edited and unedited RNA molecules. Two forms of apoB are known to circulate in the plasma of mammals. ApoB-100 is a protein primarily synthesized in the liver as a structural component of very low density lipoprotein particles. A truncated form of apoB-100, apoB-48, is synthesized in the small intestine and contains the amino-terminal 2,152 amino acids of the larger protein. This organ-specific partitioning of apoB production is the resultof RNA editing of a common apoB gene.

APOB Antibody / Apolipoprotein B
V8609SAF-100UG	NSJ Bioreagents	100 ug	EUR 349.3
Description: Post-transcriptional editing of apolipoprotein B (apoB) mRNA is regulated by APOBEC1 (also designated human (or rat) small intestinal apolipoprotein B mRNA editing protein, HEPR or REPR) in hepatic cells to achieve a steady state proportion of edited and unedited RNA molecules. Two forms of apoB are known to circulate in the plasma of mammals. ApoB-100 is a protein primarily synthesized in the liver as a structural component of very low density lipoprotein particles. A truncated form of apoB-100, apoB-48, is synthesized in the small intestine and contains the amino-terminal 2,152 amino acids of the larger protein. This organ-specific partitioning of apoB production is the resultof RNA editing of a common apoB gene.

APOB Antibody, FITC conjugated
1-CSB-PA001918LC01HU	Cusabio	EUR 380.40 EUR 402.00	100ug 50ug
Description: A polyclonal antibody against APOB. Recognizes APOB from Human. This antibody is FITC conjugated. Tested in the following application: ELISA

APOB Antibody, Biotin conjugated
1-CSB-PA001918LD01HU	Cusabio	EUR 380.40 EUR 402.00	100ug 50ug
Description: A polyclonal antibody against APOB. Recognizes APOB from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA

APOB Conjugated Antibody
C36751	SAB	100ul	EUR 476.4

APOB Polyclonal Antibody
A71904	EpiGentek	EUR 302.50 EUR 423.50	50 ul 100 ul

APOB Polyclonal Antibody
A58102	EpiGentek	EUR 684.66 EUR 117.70 EUR 302.50 EUR 423.50	100 µg 20 ul 50 ul 100 ul

Mouse Anti-Human APOB Monoclonal Antibody
CABT-26570MH	Creative Diagnostics	100ug	EUR 920.4

Apolipoprotein B (APOB) Antibody (HRP)
20-abx303087	Abbexa	EUR 493.20 EUR 2214.00 EUR 718.80 EUR 218.40 EUR 360.00	100 ug 1 mg 200 ug 20 ug 50 ug

Apolipoprotein B (APOB) Antibody (FITC)
20-abx271183	Abbexa	EUR 644.40 EUR 326.40 EUR 1996.80 EUR 927.60 EUR 510.00	100 ug 10 ug 1 mg 200 ug 50 ug

Apolipoprotein B-100 (APOB) Antibody
20-abx132335	Abbexa	EUR 393.60 EUR 994.80 EUR 526.80 EUR 184.80 EUR 309.60	100 ug 1 mg 200 ug 20 ug 50 ug

Apolipoprotein B-100 (APOB) Antibody
20-abx132342	Abbexa	EUR 393.60 EUR 978.00 EUR 510.00 EUR 184.80 EUR 309.60	100 ug 1 mg 200 ug 20 ug 50 ug

Apolipoprotein B (APOB) Antibody Pair
20-abx370667	Abbexa	EUR 2264.40 EUR 1429.20	10 × 96 tests 5 × 96 tests

Apolipoprotein B-100 (APOB) Antibody
20-abx101442	Abbexa	EUR 427.20 EUR 1095.60 EUR 560.40 EUR 184.80 EUR 326.40	100 ug 1 mg 200 ug 20 ug 50 ug

Apolipoprotein B (APOB) Antibody (FITC)
20-abx273657	Abbexa	EUR 493.20 EUR 276.00 EUR 1395.60 EUR 678.00 EUR 376.80	100 ug 10 ug 1 mg 200 ug 50 ug

Apolipoprotein B (APOB) Antibody (FITC)
20-abx274081	Abbexa	EUR 610.80 EUR 309.60 EUR 1830.00 EUR 844.80 EUR 493.20	100 ug 10 ug 1 mg 200 ug 50 ug

Apolipoprotein B (APOB) Antibody (FITC)
20-abx273903	Abbexa	EUR 594.00 EUR 309.60 EUR 1746.00 EUR 811.20 EUR 477.60	100 ug 10 ug 1 mg 200 ug 50 ug

Apolipoprotein B (APOB) Antibody (FITC)
20-abx303088	Abbexa	EUR 493.20 EUR 2214.00 EUR 718.80 EUR 218.40 EUR 360.00	100 ug 1 mg 200 ug 20 ug 50 ug

Monoclonal ApoB Antibody, Clone: 6G6
APG03156G	Leading Biology	0.1ml	EUR 633.6
Description: A Monoclonal antibody against Human ApoB. The antibodies are raised in Mouse and are from clone 6G6. This antibody is applicable in WB, FC, ICC, E

Apolipoprotein B (APOB) Antibody (Biotin)
20-abx271449	Abbexa	EUR 610.80 EUR 309.60 EUR 1846.80 EUR 861.60 EUR 493.20	100 ug 10 ug 1 mg 200 ug 50 ug

Apolipoprotein B (APOB) Antibody (Biotin)
20-abx271777	Abbexa	EUR 477.60 EUR 276.00 EUR 1296.00 EUR 644.40 EUR 376.80	100 ug 10 ug 1 mg 200 ug 50 ug

Apolipoprotein B (APOB) Antibody (Biotin)
20-abx272588	Abbexa	EUR 560.40 EUR 292.80 EUR 1612.80 EUR 760.80 EUR 410.40	100 ug 10 ug 1 mg 200 ug 50 ug

Apolipoprotein B (APOB) Antibody (Biotin)
20-abx273087	Abbexa	EUR 577.20 EUR 292.80 EUR 1696.80 EUR 794.40 EUR 427.20	100 ug 10 ug 1 mg 200 ug 50 ug

Apolipoprotein B (APOB) Antibody (Biotin)
20-abx274504	Abbexa	EUR 477.60 EUR 260.40 EUR 1178.40 EUR 594.00 EUR 376.80	100 ug 10 ug 1 mg 200 ug 50 ug

Apolipoprotein B (APOB) Antibody (Biotin)
20-abx303089	Abbexa	EUR 493.20 EUR 2214.00 EUR 718.80 EUR 218.40 EUR 360.00	100 ug 1 mg 200 ug 20 ug 50 ug

Apolipoprotein B Antibody / APOB
RQ5037	NSJ Bioreagents	100ul	EUR 356.15
Description: The APOB gene product is the main apolipoprotein of chylomicrons and low density lipoproteins. It occurs in plasma as two main isoforms, apoB-48 (~240 kDa) and apoB-100 (~516 kDa): the former is synthesized exclusively in the gut and the latter in the liver. The intestinal and the hepatic forms of apoB are encoded by a single gene from a single, very long mRNA. The two isoforms share a common N-terminal sequence. The shorter apoB-48 protein is produced after RNA editing of the apoB-100 transcript at residue 2180 (CAA->UAA), resulting in the creation of a stop codon, and early translation termination. [RefSeq]

APOB Polyclonal Antibody, HRP Conjugated
A58105	EpiGentek	EUR 684.66 EUR 302.50 EUR 423.50	100 µg 50 ul 100 ul

APOB Polyclonal Antibody, FITC Conjugated
A58104	EpiGentek	EUR 684.66 EUR 302.50 EUR 423.50	100 µg 50 ul 100 ul

APOB Polyclonal Antibody, Biotin Conjugated
A58103	EpiGentek	EUR 684.66 EUR 302.50 EUR 423.50	100 µg 50 ul 100 ul

Anti-APOB antibody
PAab00491	Lifescience Market	100 ug	EUR 463.2